Stock Price, News, Quote and Profile of HH&L ACQUISITION CO -CLASS A(NYSE:HHLA) stock

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

HH&L ACQUISITION CO -CLASS A

NYSE:HHLA (2/9/2024, 7:04:00 PM)

10.75

-0.03 (-0.23%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorN/A

GICS IndustryN/A

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Overview

Earnings (Last)

Earnings (Next)

Ins Owners

Inst Owners

Market Cap156.52M

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts

IPO

Stock Screener Links

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Company Profile

HH&L Acquisition Co. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm intends to acquire one or more healthcare businesses, with a focus on healthcare or healthcare-related companies in Asian markets with a focus on the Greater China market, or global healthcare or healthcare-related companies with a meaningful growth thesis in the Greater China or Asian markets.

Company Info

HH&L ACQUISITION CO -CLASS A

C/O Sapphire Qi Li, One Exchange Square, 8 Connaught Place Suite 3508

P: 85266796578

CEO: Richard Qi Li

Employees: 0

Website: https://www.hopuhl.com/

HHLA News

7 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday.

10 months ago - Seeking AlphaSPAC HH&L terminates merger with diagnostics developer DiaCarta (NYSE:HHLA)

Hong Kong-based SPAC HH&L (HHLA) said in a filing that it has terminated its planned merger with liquid biopsy developer DiaCarta. Read more here.

a year ago - DiaCarta, Ltd.DiaCarta Receives Accreditation by the College of American Pathologists (CAP)

PLEASNTON, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a novel molecular diagnostic test developer for cancer and infectious...

a year ago - DiaCarta, Ltd.DiaCarta Announces Five Abstracts Accepted for Presentation at AACR Annual Meeting 2023

Abstracts demonstrating XNA technology’s improvements to assay sensitivity across different technology platforms and support for use in companion...

a year ago - DiaCarta, Ltd.DiaCarta Receives U.S. FDA Emergency Use Authorization for its Monkeypox Test Kit

PLEASANTON, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a precision molecular diagnostics company, today announced that the...

a year ago - DiaCarta, Ltd.; Nonagen BioscienceDiaCarta Announces Successful Completion of Oncuria® Validation Study with Nonagen Bioscience

DiaCarta Starts to Receive Samples for Oncuria® Bladder Cancer Test at its CLIA Lab PLEASANTON, Calif. and LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE)...

HH&L ACQUISITION CO -CLASS A (HHLA)